Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bucolo

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Pharmacology|July 23, 2013
Dopamine D(3) receptor as a new pharmacological target for the treatment of depressionGian Marco Leggio, Salvatore Salomone, Claudio Bucolo, et al.
Journal of Diabetes Research|June 14, 2013
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathyClaudio Bucolo, Giuseppina Marrazzo, Chiara Bianca Maria Platania, et al.
Journal of Molecular Neuroscience : MN|July 24, 2015
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat RetinaAgata Grazia D'Amico, Grazia Maugeri, Rita Reitano, et al.
Frontiers in Pharmacology|January 24, 2022
Caffeine Protects Against Retinal InflammationFederica Conti, Francesca Lazzara, Giovanni Luca Romano, et al.
Journal of Molecular Neuroscience : MN|December 3, 2016
Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic RatsAgata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, et al.
The Journal of Pharmacy and Pharmacology|April 5, 2014
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammationClaudio Bucolo, Giuseppina Marrazzo, Chiara Bianca Maria Platania, et al.
Current Topics in Medicinal Chemistry|August 13, 2013
Clinical pharmacology of novel anti-Alzheimer disease modifying medicationsFilippo Caraci, Paolo Bosco, Gian Marco Leggio, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2008
New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alphaLbeta2 and alphaMbeta2Claudio Bucolo, Adriana Maltese, Francesco Maugeri, et al.
Progress in Brain Research|October 27, 2015
MicroRNA target prediction in glaucomaGiovanni Luca Romano, Chiara Bianca Maria Platania, Stefano Forte, et al.
Frontiers in Pharmacology|November 22, 2021
Effects of Vitamin D<sub>3</sub> and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated <i>in vitro</i> Paradigms of Age-Related Macular DegenerationFrancesca Lazzara, Federica Conti, Chiara Bianca Maria Platania, et al.
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Pharmacology|July 23, 2013
Dopamine D(3) receptor as a new pharmacological target for the treatment of depressionGian Marco Leggio, Salvatore Salomone, Claudio Bucolo, et al.
Journal of Diabetes Research|June 14, 2013
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathyClaudio Bucolo, Giuseppina Marrazzo, Chiara Bianca Maria Platania, et al.
Journal of Molecular Neuroscience : MN|July 24, 2015
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat RetinaAgata Grazia D'Amico, Grazia Maugeri, Rita Reitano, et al.
Frontiers in Pharmacology|January 24, 2022
Caffeine Protects Against Retinal InflammationFederica Conti, Francesca Lazzara, Giovanni Luca Romano, et al.
Journal of Molecular Neuroscience : MN|December 3, 2016
Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic RatsAgata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, et al.
The Journal of Pharmacy and Pharmacology|April 5, 2014
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammationClaudio Bucolo, Giuseppina Marrazzo, Chiara Bianca Maria Platania, et al.
Current Topics in Medicinal Chemistry|August 13, 2013
Clinical pharmacology of novel anti-Alzheimer disease modifying medicationsFilippo Caraci, Paolo Bosco, Gian Marco Leggio, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2008
New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alphaLbeta2 and alphaMbeta2Claudio Bucolo, Adriana Maltese, Francesco Maugeri, et al.
Progress in Brain Research|October 27, 2015
MicroRNA target prediction in glaucomaGiovanni Luca Romano, Chiara Bianca Maria Platania, Stefano Forte, et al.
Frontiers in Pharmacology|November 22, 2021
Effects of Vitamin D<sub>3</sub> and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated <i>in vitro</i> Paradigms of Age-Related Macular DegenerationFrancesca Lazzara, Federica Conti, Chiara Bianca Maria Platania, et al.
Pageof 21